The comedian, actor and writer, Pete Davidson, has recently checked into a mental health treatment center. He is best known for his work on “Saturday Night Live.” He was a cast member from 2014 to 2022.

Per an article written by People, the comedian (30) is taking time off to focus on his well being. 

He has recently completed over 200 live stand-up comedy shows across the country. He has also been working on some movies and about to release another Netflix special called “Turbo Fonzarelli” due out in January.

 

View this post on Instagram

 

A post shared by pete davidson (@petedavidson.93)

A source disclosed to People that Davidson has always prioritized his mental health due to his history of ”borderline personality disorder and severe post-traumatic stress disorder.” In addition, the comedian is working hard to remain sober. Last summer Davidson had checked himself in for treatment.

Additionally, Davidson has been open about his struggles with substance abuse, having sought treatment multiple times, and emphasizing how maintaining sobriety has been crucial for his mental health. He credits therapy and medication with helping him manage his conditions.Through interviews, social media, and his comedy, Davidson addresses his mental health issues openly. This contributes to a greater public understanding and inspires many who face similar challenges.

Davidson’s comedy often draws from his own life experiences, including his struggles with mental health and the loss of his father, a firefighter who died in the September 11 attacks.

The comedian admitted to using ketamine daily for the past four years. Ketamine is being used more for mental health treatment. It works as an anesthetic.

Per Web MD “Ketamine can produce feelings of unreality; visual and sensory distortions; a distorted feeling about one’s body; temporary unusual thoughts and beliefs; and a euphoria or a buzz,” says John Krystal, MD, chief of psychiatry at Yale-New Haven Hospital and Yale School of Medicine in Connecticut, where he is a leader in studying ketamine’s antidepressant effects.